Benjamin Schilling

Title: The Innovative Contributions of Benjamin Schilling

Introduction

Benjamin Schilling is a notable inventor based in Sacramento, CA. He has made significant strides in the field of biotechnology, particularly in carbon dioxide fixation. With a total of 2 patents to his name, Schilling's work focuses on developing methods that enhance the production of valuable products from carbon dioxide.

Latest Patents

Schilling's latest patents include groundbreaking techniques for carbon dioxide fixation. His innovations involve genetically engineered cells that allow for the production of various value products from CO. The contemplated cells have a Calvin-Benson-Bassham (CBB) cycle that is genetically modified, enabling the withdrawal of two molecules of CO fixed in the CBB cycle as a single C2 compound. This process includes enzymatic activity that generates the single C2 compound from a compound of the CBB cycle, ensuring that further modifications do not introduce additional recombinant enzymatic activities outside the existing catalytic activities in the CBB cycle.

Career Highlights

Benjamin Schilling is currently associated with Easel Biotechnologies LLC, where he continues to push the boundaries of biotechnological research. His work is instrumental in developing sustainable methods for carbon fixation, which has significant implications for environmental sustainability and industrial applications.

Collaborations

Some of Schilling's notable coworkers include Yi-Xin Huo and Shahrooz Rabizadeh. Their collaborative efforts contribute to the innovative research environment at Easel Biotechnologies LLC.

Conclusion

Benjamin Schilling's contributions to biotechnology, particularly in carbon dioxide fixation, highlight his role as an influential inventor. His patents and ongoing research are paving the way for sustainable solutions in the industry.